Related Experiment Videos
NKT cells: potential targets for autoimmune disease therapy?
1Division of development Immunology, La Jolla Institute for Allergy & Immunology, San Diego, CA, USA.
Tissue Antigens
|July 30, 2002
Summary
Natural killer T (NKT) cells recognize glycolipids via CD1d molecules and are involved in autoimmune diseases. This review examines NKT cell roles in conditions like type 1 diabetes and lupus, exploring therapeutic potential.
Area of Science:
- Immunology
- Autoimmunity
- Cellular Biology
Background:
- Natural killer T (NKT) cells are a distinct T cell population recognizing glycolipid antigens presented by the CD1d molecule.
- These cells are significant producers of cytokines that regulate immune responses.
- NKT cells have been implicated in the pathogenesis of various autoimmune diseases.
Purpose of the Study:
- To review the evidence linking NKT cells to autoimmune diseases.
- To discuss the potential of NKT cell-targeted therapies for autoimmune disease prevention.
Main Methods:
- Literature review of studies investigating NKT cells in autoimmune disease models and human patients.
- Analysis of cytokine production profiles of NKT cells.
- Evaluation of therapeutic strategies involving NKT cell manipulation.
Main Results:
- Evidence suggests NKT cell involvement in Type 1 diabetes, experimental autoimmune encephalomyelitis (multiple sclerosis model), systemic lupus erythematosus, and scleroderma.
- NKT cells' immunoregulatory functions highlight their dual role in immunity and autoimmunity.
- Therapeutic manipulation of NKT cells shows promise for clinical applications.
Conclusions:
- NKT cells play a critical role in the development and progression of multiple autoimmune diseases.
- Targeting NKT cells offers a potential strategy for novel autoimmune disease treatments.